Capula Management Ltd grew its position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 367.5% in the 1st quarter, Holdings Channel reports. The firm owned 23,571 shares of the company’s stock after acquiring an additional 18,529 shares during the quarter. Capula Management Ltd’s holdings in Astera Labs were worth $2,583,000 at the end of the most recent quarter.
A number of other institutional investors also recently modified their holdings of the company. Lido Advisors LLC raised its stake in Astera Labs by 0.5% during the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock worth $2,046,000 after buying an additional 57 shares during the last quarter. Perigon Wealth Management LLC raised its position in shares of Astera Labs by 6.2% in the 4th quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock worth $208,000 after acquiring an additional 73 shares in the last quarter. Sound Income Strategies LLC lifted its stake in shares of Astera Labs by 9.2% in the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock valued at $164,000 after purchasing an additional 76 shares during the period. Venturi Wealth Management LLC lifted its stake in shares of Astera Labs by 2.6% in the 4th quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock valued at $546,000 after purchasing an additional 84 shares during the period. Finally, Goldstein Advisors LLC boosted its position in shares of Astera Labs by 5.8% during the 4th quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock valued at $268,000 after purchasing an additional 88 shares in the last quarter. 60.47% of the stock is owned by institutional investors.
Astera Labs Stock Performance
ALAB stock opened at $326.97 on Friday. The stock’s 50 day simple moving average is $357.77 and its 200 day simple moving average is $225.19. Astera Labs, Inc. has a fifty-two week low of $97.89 and a fifty-two week high of $499.48. The company has a market cap of $56.05 billion, a P/E ratio of 220.93, a price-to-earnings-growth ratio of 3.83 and a beta of 3.66.
Wall Street Analysts Forecast Growth
A number of brokerages have weighed in on ALAB. Citigroup downgraded Astera Labs from a “buy” rating to a “market perform” rating in a report on Tuesday, May 26th. Morgan Stanley increased their price target on Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May 26th. TD Cowen lifted their price objective on shares of Astera Labs from $225.00 to $425.00 and gave the company a “hold” rating in a research note on Monday, July 13th. Finally, Bank of America increased their target price on shares of Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research note on Tuesday, June 23rd. Twelve equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $282.00.
Get Our Latest Stock Report on Astera Labs
Insider Transactions at Astera Labs
In other Astera Labs news, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the sale, the chief operating officer owned 5,064,213 shares in the company, valued at approximately $1,470,141,033.90. The trade was a 7.32% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 139,951 shares of the business’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $200.16, for a total transaction of $28,012,592.16. Following the sale, the chief executive officer owned 3,929,183 shares of the company’s stock, valued at $786,465,269.28. This trade represents a 3.44% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,676,845 shares of company stock valued at $444,928,806 over the last ninety days. 10.40% of the stock is owned by company insiders.
Astera Labs Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Read More
- Five stocks we like better than Astera Labs
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
